Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route.

Ahmed OAA, Fahmy UA, Badr-Eldin SM, Aldawsari HM, Awan ZA, Asfour HZ, Kammoun AK, Caruso G, Caraci F, Alfarsi A, Al-Ghamdi RA, Al-Ghamdi RA, Alhakamy NA

Open source

DOI: 10.3390/nano10071270
Published: 2020 Jun 29
Container: Nanomaterials (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/nano10071270,
  title = {Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route.},
  author = {Ahmed OAA and Fahmy UA and Badr-Eldin SM and Aldawsari HM and Awan ZA and Asfour HZ and Kammoun AK and Caruso G and Caraci F and Alfarsi A and Al-Ghamdi RA and Al-Ghamdi RA and Alhakamy NA},
  year = {2020},
  journal = {Nanomaterials (Basel, Switzerland)},
  doi = {10.3390/nano10071270},
  url = {https://doi.org/10.3390/nano10071270}
}

RIS

TY  - JOUR
TI  - Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route.
AU  - Ahmed OAA
AU  - Fahmy UA
AU  - Badr-Eldin SM
AU  - Aldawsari HM
AU  - Awan ZA
AU  - Asfour HZ
AU  - Kammoun AK
AU  - Caruso G
AU  - Caraci F
AU  - Alfarsi A
AU  - Al-Ghamdi RA
AU  - Al-Ghamdi RA
AU  - Alhakamy NA
PY  - 2020
JO  - Nanomaterials (Basel, Switzerland)
DO  - 10.3390/nano10071270
UR  - https://doi.org/10.3390/nano10071270
ER  -

APA

OAA, A., UA, F., SM, B., HM, A., ZA, A., HZ, A., AK, K., G, C., F, C., A, A., RA, A., RA, A., & NA, A. (2020). Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route.. Nanomaterials (Basel, Switzerland). https://doi.org/10.3390/nano10071270

Source records

pubmed · retrieved 2026-09-25T12:58:52.300Z